These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 28025775)

  • 1. Systemic Treatment of Adult Atopic Dermatitis: A Review.
    Megna M; Napolitano M; Patruno C; Villani A; Balato A; Monfrecola G; Ayala F; Balato N
    Dermatol Ther (Heidelb); 2017 Mar; 7(1):1-23. PubMed ID: 28025775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis.
    Frankel HC; Qureshi AA
    Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis.
    Fröschl B; Arts D; Leopold C
    GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of atopic eczema.
    Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM
    GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
    Siegfried EC; Jaworski JC; Kaiser JD; Hebert AA
    BMC Pediatr; 2016 Jun; 16():75. PubMed ID: 27267134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atopic dermatitis: understanding the disease and its management.
    Levy ML
    Curr Med Res Opin; 2007 Dec; 23(12):3091-103. PubMed ID: 17971284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atopic dermatitis: a review of topical treatment options.
    Simpson EL
    Curr Med Res Opin; 2010 Mar; 26(3):633-40. PubMed ID: 20070141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tacrolimus for atopic dermatitis.
    Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis.
    Anderson P; Austin J; Lofland JH; Piercy J; Joish VN
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1571-1585. PubMed ID: 34268709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Scoping Literature Review of Publications Supporting Treatment Guidelines for Pediatric Atopic Dermatitis in Contrast to Clinical Practice Patterns.
    Siegfried EC; Jaworski JC; Mina-Osorio P
    Dermatol Ther (Heidelb); 2018 Sep; 8(3):349-377. PubMed ID: 29858763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab.
    Blauvelt A; Wollenberg A; Eichenfield LF; Zhang H; Sierka D; Khokhar FA; Vakil J; Shabbir A; Marco AR; Cyr SL
    Adv Ther; 2023 Jan; 40(1):367-380. PubMed ID: 36318387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Itch in Atopic Dermatitis - What Is New?
    Legat FJ
    Front Med (Lausanne); 2021; 8():644760. PubMed ID: 34026782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis.
    Abramovits W; Hung P; Tong KB
    Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delgocitinib in atopic dermatitis.
    Ho J; Molin S
    Drugs Today (Barc); 2021 Dec; 57(12):719-731. PubMed ID: 34909801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical agents for the treatment of atopic dermatitis.
    Diaz A; Guttman-Yassky E
    Expert Rev Clin Immunol; 2019 Apr; 15(4):369-382. PubMed ID: 30587053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of Systemic Treatment Options for Adult Atopic Dermatitis.
    Gooderham M; Lynde CW; Papp K; Bourcier M; Guenther L; Gulliver W; Hong CH; Poulin Y; Sussman G; Vender R
    J Cutan Med Surg; 2017; 21(1):31-39. PubMed ID: 27635033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology.
    Nowicki R; Trzeciak M; Wilkowska A; Sokołowska-Wojdyło M; Ługowska-Umer H; Barańska-Rybak W; Kaczmarski M; Kowalewski C; Kruszewski J; Maj J; Silny W; Śpiewak R; Petranyuk A
    Postepy Dermatol Alergol; 2015 Aug; 32(4):239-49. PubMed ID: 26366146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study.
    Kimball AB; Delevry D; Yang M; Chuang CC; Wang Z; Bégo-Le-Bagousse G; Martins B; Wu E; Shumel B; Wang J; Sierka D; Chao J; Strober B
    Dermatol Ther (Heidelb); 2023 Sep; 13(9):2107-2120. PubMed ID: 37552431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.